Associate Director of Emerging Innovation
David is Associate Director of Emerging Innovations in AstraZeneca’s Biopharmaceutical R&D Unit, where he is responsible for driving entrepreneurial activities and identifying game-changing technologies for use across R&D. A neuroscientist by training, David holds a PhD in Molecular Neuroscience from the University of Cambridge and prior to joining AZ was a strategy consultant for PwC’s Strategy& where he advised Life Sciences companies and public organisations on topics related to R&D strategy, M&A, pricing and market access, and growth strategy. David is passionate about Inclusion and Diversity and is a member of AstraZeneca's corporate-wide Inclusion & Diversity Council. David also co-chairs AstraZeneca's LGBTQIA+ Employee Resource Group AZPride, where he has driven strategic initiatives on global LGBTQIA+ inclusion and has spoken externally about the impact of Employee Resource Groups.